{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:13:06Z","timestamp":1788286386345,"version":"build-2803163510"},"reference-count":0,"publisher":"American Society of Hematology","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Infection is a major cause of morbidity and mortality in myelodysplastic syndromes (MDS), yet infection risk remains incompletely defined in the contemporary treatment era. We conducted a retrospective study of 708 patients with MDS to characterize the incidence, microbiology, temporal dynamics, and predictors of infection-related hospitalization over two decades. Overall, 78.8% (n=558) of patients required hospitalization, of which 69.9% were infection related. Infection-related hospitalization was independently associated with inferior overall survival. In multivariable Cox proportional hazards model, comorbidity burden, red blood cell transfusion dependence, higher IPSS-R risk, exposure to chemotherapy or stem cell transplantation, and severe neutropenia independently predicted infection. Among azacitidine-treated patients, 71.4% experienced infection-related hospitalization, with nearly three-quarters occurring within the first six cycles, identifying a critical early vulnerability window. Neutropenia remained the dominant driver of infection risk; however, immune dysfunction independently increased susceptibility. Low monocyte counts, cytokine dysregulation, and TP53 mutations identified high-risk patients despite preserved neutrophil counts, reflecting impaired myeloid reserve. Consistent with this dynamic vulnerability, recent infection or severe neutropenia (&amp;lt;0.5\u00d710\u2079\/L) increased subsequent infection risk by 2.47-fold. We observed a concerning shift in antimicrobial resistance, with 14% of Gram-negative infections producing extended-spectrum beta-lactamases, 21% of Pseudomonas aeruginosa isolates resistant to piperacillin-tazobactam, and vancomycin-resistant enterococci prevalence increasing from 14% to 46%. Together, these findings identify infection in MDS as a dynamic, prognostically important complication driven by cytopenia, treatment, and immune dysfunction. This supports time-adapted risk stratification, targeted prevention, and antimicrobial stewardship, particularly during early treatment and high-risk disease phase.<\/jats:p>","DOI":"10.1182\/bloodadvances.2026019689","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:15:38Z","timestamp":1788282938000},"update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Infection risk in myelodysplastic syndromes is dynamic and immune driven"],"prefix":"10.1182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9499-0292","authenticated-orcid":false,"given":"Alyssa","family":"Pradhan","sequence":"first","affiliation":[{"name":"University of Sydney, Camperdown, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakchha","family":"Chhetri","sequence":"additional","affiliation":[{"name":"Central Adelaide Local Health Network, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5647-4673","authenticated-orcid":false,"given":"Philip","family":"Selby","sequence":"additional","affiliation":[{"name":"Central Adelaide Local Health Network, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Sapio","sequence":"additional","affiliation":[{"name":"Central Adelaide Local Health Network, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Maritz","sequence":"additional","affiliation":[{"name":"Royal Adelaide Hospital, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6414-6441","authenticated-orcid":false,"given":"Carla","family":"Toop","sequence":"additional","affiliation":[{"name":"Central Adelaide Local Health Network, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3181-7852","authenticated-orcid":false,"given":"Chung Hoow","family":"Kok","sequence":"additional","affiliation":[{"name":"SA Pathology, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2315-091X","authenticated-orcid":false,"given":"Monika M","family":"Kutyna","sequence":"additional","affiliation":[{"name":"South Australian Health and Medical Research Institute, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop K.","family":"Enjeti","sequence":"additional","affiliation":[{"name":"University of Newcastle, Newcastle, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7361-9491","authenticated-orcid":false,"given":"Nirmal","family":"Robinson","sequence":"additional","affiliation":[{"name":"University of South Australia and SA Pathology, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8284-4746","authenticated-orcid":false,"given":"Emmanuel","family":"Gnanamanickam","sequence":"additional","affiliation":[{"name":"Adelaide University, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-1610","authenticated-orcid":false,"given":"Morgyn Sylvia","family":"Warner","sequence":"additional","affiliation":[{"name":"Central Adelaide Local Health Network, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2051-5998","authenticated-orcid":false,"given":"Renjy","family":"Nelson","sequence":"additional","affiliation":[{"name":"Central Adelaide Local Health Network, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6666-3056","authenticated-orcid":false,"given":"Devendra K.","family":"Hiwase","sequence":"additional","affiliation":[{"name":"Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,9,1]]},"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2026019689\/2542831\/bloodadvances.2026019689.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/doi\/10.1182\/bloodadvances.2026019689\/2542831\/bloodadvances.2026019689.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:15:38Z","timestamp":1788282938000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/doi\/10.1182\/bloodadvances.2026019689\/570681\/Infection-risk-in-myelodysplastic-syndromes-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026019689","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"bloodadvances.2026019689"}}